Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Dividends Score | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| INTZ | INTRUSION INC | $3.48M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| PPBT | PURPLE BIOTECH LTD | $9.72M | N/A | N/A | N/A | N/A | N/A | N/A | |||
| IQ | IQIYI INC | $4.40B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| ASLN | ASLAN PHARMACEUTICALS LTD | $8.25M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| AGEN | AGENUS INC | $135.31M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| CLDI | CALIDI BIOTHERAPEUTICS INC | $5.93M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| CLNN | CLENE INC | $43.02M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| LIFE | ATYR PHARMA INC | $109.76M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| BPTH | BIO-PATH HOLDINGS INC | $1.82M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| BIOL | BIOLASE INC | $4.91M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| KZR | KEZAR LIFE SCIENCES INC | $60.13M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| CKPT | CHECKPOINT THERAPEUTICS INC | $51.21M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| OCUP | OCUPHIRE PHARMA INC | $38.21M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| BNED | BARNES & NOBLE EDUCATION INC | $10.95M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| GOEV | CANOO INC | $204.14M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| APTO | APTOSE BIOSCIENCES INC | $19.33M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| APLM | APOLLOMICS INC | $42.78M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| GOSS | GOSSAMER BIO INC | $166.48M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| EVA | ENVIVA INC | $29.50M | N/A | -37.00% | $0.9050 | N/A | N/A | 0 | |||
| AADI | AADI BIOSCIENCE INC | $45.18M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| SONN | SONNET BIOTHERAPEUTICS HOLDINGS INC | $5.46M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| IFRX | INFLARX NV | $80.08M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| MVST | MICROVAST HOLDINGS INC | $144.65M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| MRNS | MARINUS PHARMACEUTICALS INC | $78.69M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| VIRX | VIRACTA THERAPEUTICS INC | $33.30M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| GNLX | GENELUX CORP | $93.49M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| TARA | PROTARA THERAPEUTICS INC | $34.30M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| MIST | MILESTONE PHARMACEUTICALS INC | $90.35M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| YTEN | YIELD10 BIOSCIENCE INC | $3.96M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| FEMY | FEMASYS INC | $29.39M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| INAB | IN8BIO INC | $45.02M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| IMRX | IMMUNEERING CORP | $47.73M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| CVKD | CADRENAL THERAPEUTICS INC | $6.82M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| NTBL | NOTABLE LABS LTD | $8.84M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| GRTS | GRITSTONE BIO INC | $72.47M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| SYBX | SYNLOGIC INC | $22.25M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| LUXH | LUXURBAN HOTELS INC | $36.38M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| GEVO | GEVO INC | $170.75M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| LUMO | LUMOS PHARMA INC | $22.70M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| PASG | PASSAGE BIO INC | $68.39M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| SGMT | SAGIMET BIOSCIENCES INC | $136.59M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| PRST | PRESTO AUTOMATION INC | $13.73M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| SPRB | SPRUCE BIOSCIENCES INC | $28.85M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| MBRX | MOLECULIN BIOTECH INC | $10.25M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| HOOK | HOOKIPA PHARMA INC | $75.70M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| TPST | TEMPEST THERAPEUTICS INC | $75.90M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| VOR | VOR BIOPHARMA INC | $128.16M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| PGEN | PRECIGEN INC | $348.49M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| IKNA | IKENA ONCOLOGY INC | $65.15M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| PSTX | POSEIDA THERAPEUTICS INC | $208.42M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| FBIO | FORTRESS BIOTECH INC | $34.81M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| IVA | INVENTIVA SA | $171.46M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| CMPS | COMPASS PATHWAYS PLC | $529.88M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| CARA | CARA THERAPEUTICS INC | $38.64M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| CLRB | CELLECTAR BIOSCIENCES INC | $100.33M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| AMPX | AMPRIUS TECHNOLOGIES INC | $160.30M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| OTLK | OUTLOOK THERAPEUTICS INC | $106.71M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| EOSE | EOS ENERGY ENTERPRISES INC | $155.43M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| UBX | UNITY BIOTECHNOLOGY INC | $25.01M | N/A | 0.00% | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.